Does Long-Term Entecavir Treatment Really Reduce Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection? Reply

被引：1
|
作者：
Hosaka, Tetsuya [1 ]
Suzuki, Fumitaka [1 ]
Kumada, Hiromitsu [1 ]
机构：
[1] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan
来源：
HEPATOLOGY | 2014年 / 59卷 / 05期
关键词：
LAMIVUDINE;
D O I：
10.1002/hep.26774
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2053 / 2054
页数：2
相关论文
共 50 条
  • [31] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Jung Woo Shin
    Joonho Jeong
    Seok Won Jung
    Seung Bum Lee
    Bo Ryung Park
    Min-Ju Kim
    Eun Ji Park
    Neung Hwa Park
    Digestive Diseases and Sciences, 2021, 66 : 1739 - 1750
  • [32] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Shin, Jung Woo
    Jeong, Joonho
    Jung, Seok Won
    Lee, Seung Bum
    Park, Bo Ryung
    Kim, Min-Ju
    Park, Eun Ji
    Park, Neung Hwa
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750
  • [33] Hepatocellular carcinoma after renal transplantation: The long-term impact of cirrhosis on chronic hepatitis B virus infection
    Fan, W. -C.
    King, K. -L.
    Loong, C. -C.
    Wu, C. -W.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2080 - 2083
  • [34] Long-term antiviral efficacy of entecavir in patients with hepatitis B virus-related cirrhosis
    Xu, Yan
    Zhou, Changyu
    Zhang, Yonggui
    Ji, Shangwei
    Zhao, Ping
    Guo, Honghua
    Jiao, Jian
    Li, Yan
    Wang, Jiangbin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 394 - 394
  • [35] Occult Hepatitis B Virus Infection and Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis C Reply
    Lok, Anna S.
    Everhart, James E.
    HEPATOLOGY, 2011, 54 (01) : 374 - 374
  • [36] Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection
    Tajiri, Kazuto
    Hayashi, Yuka
    Murayama, Aiko
    Muraishi, Nozomu
    Minemura, Masami
    Yasuda, Ichiro
    VIRUSES-BASEL, 2025, 17 (01):
  • [37] The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors
    Li, Zhi-Qin
    Hu, Chun-Ling
    Yu, Ping
    Gu, Xin-Yu
    Zhang, Jia-Jia
    Li, Hua
    Zhang, Hong-Yu
    Lv, Jun
    Liu, Yan-Min
    Zeng, Qing-Lei
    Yan, Jing-Ya
    Yu, Zu-Jiang
    Zhang, Yi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (03) : 311 - 318
  • [38] Entecavir for the treatment of chronic hepatitis B virus infection
    Matthews, SJ
    CLINICAL THERAPEUTICS, 2006, 28 (02) : 184 - 203
  • [39] Nucleoside analogue treatment can not reduce the incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Yasunaka, Tetsuya
    Ikeda, Fusao
    Wada, Nozomu
    Morimoto, Yuuki
    Kuwaki, Kenji
    Takaki, Akinobu
    Yamamoto, Kazuhide
    HEPATOLOGY, 2013, 58 : 671A - 671A
  • [40] Long-term Effectiveness of Entecavir among Hepatitis B Patients in Taiwan
    Yeh, Yi-Chun
    Liu, Chun-Jen
    Chen, Pei-Jer
    Lai, Mei-Shu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 346 - 346
12345